Français

Contact us in Ontario


The Ontario Region takes in a large collection of towns and cities that are home to a diverse and ever-growing population. Ontario is the home of a strong community of volunteers, donors and sponsors, as well as an innovative team of researchers and healthcare professionals. These people are the heart and soul of our organization, and there are so many exciting ways to get involved! Every volunteer, donor, researcher and sponsor helps us to improve the lives of those affected by Crohn’s disease and ulcerative colitis, and brings us closer to finding cures.

Senior Director, Community Engagement
Josephine Cavarra

416-920-5035 ext. 244

Development Coordinator, Eastern Ontario
Meera Manghani

647-684-6894

Development Coordinator, Central Ontario
Cindy Weiss

416-920-5035 ext. 239

Development Coordinator, Southwestern Ontario
Shie Gorman

519-496-6703  

Development Coordinator, Toronto
Kate Zahnow

1-800-387-1479

Development Coordinator, Northern Ontario
Nicole Sage

705-890-9782

Events

New Frontiers

New Frontiers 2023

Join us for an evening of inspiration and celebration as we highlight the advancements inflammatory bowel disease (IBD) research has had on the Crohn's disease and ulcerative colitis community and ...

 • 
The Westin Harbour Castle 1 Harbour Square
Toronto
 • 
Gutsy Runway women wearing toilet paper dress on red carpet with photo's being taken of her

Toilet Paper Dress Fashion Show Fundraiser

Roll with us down the Gutsy Runway!Join us for a one-of-a-kind toilet paper fashion show! Purchase your event tickets, donate, sponsor, or enter our toilet paper dress contest! Please visit our ...

 • 
The Northbury Hotel and Conference Centre 50 Brady St, Sudbury ON P3E 1C8
Sudbury
 • 
Remember to bookmark this page.

Toronto Office

2110-439 University Avenue
Toronto, ON M5G 1Y8

416-920-5035 or 1-800-387-1479

Search by Postal Code

News

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

Send an eCard to Friends or Family Members in Support of Crohn's and Colitis Canada

Send an eCard to Friends or Family Members in Support of Crohn's and Colitis Canada

Today, September 30, Marks the Second National Day for Truth and Reconciliation in Canada

Today, September 30, Marks the Second National Day for Truth and Reconciliation in Canada

 2 3 4 5 6 7 8 9 10 11